Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities
S Ailawadhi, Y Adu, RD Frank, S Das, DO Hodge… - Blood Cancer …, 2024 - nature.com
Multiple myeloma (MM) therapeutics have evolved tremendously in recent years, with
significant improvement in patient outcomes. As newer treatment options are developed …
significant improvement in patient outcomes. As newer treatment options are developed …
Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
Health disparities present a barrier to successful oncology treatment. The potential for
precision oncology to reduce health disparities has not previously been analyzed. We …
precision oncology to reduce health disparities has not previously been analyzed. We …
Comparison of outcomes by race among a population-based matched sample of multiple myeloma patients
Purpose It is important to understand racial inequities in multiple myeloma treatment and
survival, particularly in the Midwest where clear differences exist in cancer incidence and …
survival, particularly in the Midwest where clear differences exist in cancer incidence and …
Income and education affect prognosis and treatment in symptomatic myeloma
G Larfors, K Carlson, C Day, S Einarsdottir… - Annals of …, 2025 - Springer
Despite advancements in multiple myeloma treatment, prognostic variability persists. We
investigated the impact of income and education on treatment and survival in a country with …
investigated the impact of income and education on treatment and survival in a country with …
[HTML][HTML] The Impact of Social Determinants of Health on Peripheral T cell Lymphoma Outcomes: Treatment center-type emerges as a powerful prognostic indicator
M Mead, B Glenn, J Tuscano, A Saha, S Larson… - … Myeloma and Leukemia, 2024 - Elsevier
Background Prognostic models in peripheral T cell lymphoma (PTCL) have identified
biological factors including age, performance status, LDH, and bone marrow involvement as …
biological factors including age, performance status, LDH, and bone marrow involvement as …